The Pharmaceutical Industry Ethical – prescription Highly regulated manufacturing, distribution, marketing Over the Counter/Consumer Products Discretionary Market driven
CGMP Current Good Manufacturing Practice – on Human use pharmaceuticals Issued by: Division of Mfg. and Product Quality Office of Compliance Center for Drug Evaluation & Research U. S. Food & Drug Administration
Marketing Considerations Web Site Well constructed; complete Clearly Identify “Diversity Classification”
Marketing Considerations Web Site Well constructed; complete Clearly Identify “Diversity Classification” Identify your Market Size, Location, Commodity, First/Second Tier
Marketing Considerations Web Site Well constructed; complete Clearly Identify “Diversity Classification” Identify your Market Size, Location, Commodity, First/Second Tier Contacts Industry Memberships – ie, APA, AACP, PDE (Phila. Drug Exchange) Professional Memberships – ISM, NAWBO, NMSDC
Marketing Considerations Web Site Well constructed; complete Clearly Identify “Diversity Classification” Identify your Market Size, Location, Commodity, First/Second Tier Contacts Industry Memberships – ie, APA, AACP, PDE (Phila. Drug Exchange) Professional Memberships – ISM, NAWBO, NMSDC Follow Up Trade Show, professional contacts Periodic s of current information Celebrate Successes Press releases, Blasts
Final Considerations Deliver!!!!